Pfizer Inc (PFE)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$25.85

Buy

$25.88

arrow-up$0.05 (+0.19%)

Prices updated at 13 Dec 2025, 00:59 EST

Prices minimum 15 mins delay

Prices in USD

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	59,554m	63,627m
	34,600m	45,776m
	4,223m	14,830m
	7.09	23.31
	2,119m	8,031m
	9,557m	18,127m
Sales, General and administrative	14,771m	14,730m
Interest expenses	2,209m	3,091m
Provision for income taxes	-1,115m	-28m
Operating expenses	30,377m	30,946m
Income before taxes	1,058m	8,023m
Net income available to common shareholders	2,119m	8,031m
	0.38	1.42
Net interest income	-585m	-2,546m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.37	1.41
Free cash flow per share	1.4293	1.4539
Book value/share	17.1686	16.2848
Debt equity ratio	0.679657	0.642869

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	43,333m	50,358m
Current liabilities	47,794m	42,995m
Total capital	149,513m	144,906m
Total debt	70,845m	63,649m
Total equity	89,014m	88,203m
Total non current liabilities	-	-
Loans	60,499m	56,703m
Total assets	226,501m	213,396m
Total liabilities	-	-
Cash and cash equivalents	2,853m	1,043m
Common stock	5,646m	5,667m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	468m	2,917m
Cash dividends paid	-9,247m	-9,512m
	4,793m	9,835m
Investments (gains) losses	-32,278m	2,652m
	2,917m	1,107m
Net income	-	-
	8,700m	12,744m
	-3,907m	-2,909m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.